1. Home
  2. MMD vs EOLS Comparison

MMD vs EOLS Comparison

Compare MMD & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MainStay MacKay DefinedTerm Municipal Opportunities Fund

MMD

MainStay MacKay DefinedTerm Municipal Opportunities Fund

HOLD

Current Price

$15.14

Market Cap

279.8M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$5.14

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMD
EOLS
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.8M
284.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MMD
EOLS
Price
$15.14
$5.14
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
65.9K
748.2K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
4.88%
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$13.27
Revenue Next Year
N/A
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$14.32
$3.86
52 Week High
$15.82
$12.28

Technical Indicators

Market Signals
Indicator
MMD
EOLS
Relative Strength Index (RSI) 51.44 63.89
Support Level $14.96 $4.02
Resistance Level $15.17 $7.29
Average True Range (ATR) 0.19 0.23
MACD 0.03 0.12
Stochastic Oscillator 64.79 94.98

Price Performance

Historical Comparison
MMD
EOLS

About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund

NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: